Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Analyst: Broadcom demand remains concentrated

Analyst: Broadcom demand remains concentrated

老虎证券老虎证券2026/06/04 09:00
Show original
Barringer pointed out that although the faster-growing chip division at Broadcom has lower profit margins, overall demand remains strong. He stated that this shift will dilute Broadcom's profitability, as the company needs to generate more revenue to achieve the same level of profit. Barringer added that, more broadly, the company's performance is positive, but Broadcom is struggling to meet and surpass the market's high expectations. Broadcom's pre-market share price fell by more than 12%.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage

Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.

智通财经2026/09/15 03:21
Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage